Listar por autor "Luño Fernández, Elisa"
Mostrando ítems 1-20 de 38
-
Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): clinical and biological features and comparison with other acute myeloid leukemias with cytogenetic aberrations involving long arm of chromosome 3
Raya, José María; Martín Santos, Taida; Luño Fernández, Elisa
; Sanzo Lombardero, María del Carmen; Pérez Sirvent, Maria Luz; Such, Esperanza; Navarro, José Tomás; Milla, Fuensanta; Alonso, Esther; Domingo, Alicia; Grupo Espanol de Citologia Hematologica (GECH); Sociedad Espanola de Hematologia y Hemoterapia (SEHH) (Maney Publishing, 2015-02)
-
Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletion
Puiggros, Anna; Delgado, Julio; Rodríguez-Vicente, Anna; Collado, Rosa; Luño Fernández, Elisa; Grau, Javier; Hernández, José Ángel; Marugán, Isabel; Ardanaz, María Teresa; González, Teresa; Grupo Cooperativo Español de Citogenética Hematológica (GCECGH); Grupo Español de Leucemia Linfática Crónica (GELLC) (British Society of Haematology, 2013)
-
Complex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndrome
Valcárcel Ferreiras, David; Ademà Llobet, Vera; Solé Ristol, Francesc; Luño Fernández, Elisa (American Society of Clinical Oncology, 2013)
-
Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry.
Espinet, Blanca; Ferrer, A.; Bellosillo, B.; Nonell, L.; Luño Fernández, Elisa (American Association for Cancer Research, 2014)
-
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: Results from the Spanish Registry
Bernal del Castillo, Teresa; Martínez Camblor, Pablo; Sánchez García, Joaquín; Paz, Raquel de; Luño Fernández, Elisa; Nomdedeu, Benet; Ardanaz, María Teresa; Pedro, Carme; Amigo, M. L.; Xicoy, Blanca (Nature Publishing Group, 2015)
-
The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis
Hernández Boluda, Juan Carlos; Pereira, Arturo; Gómez, Montse; Boque, Concepción; Luño Fernández, Elisa (Ferrata Storti Foundation : The European Hematology Association, 2014)